Zhang Tianyue, Xu Jingya, Ye Lingxia, Lin Xiling, Xu Yufeng, Pan Xiaowen, Weng Xifang, Ye Chuyu, Fan Longjiang, Ren Yuezhong, Shan Peng-Fei
Department of Endocrinology, the Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China.
Department of Ophthalmology, the Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China.
J Cancer. 2021 Mar 15;12(10):2855-2865. doi: 10.7150/jca.52282. eCollection 2021.
Recently, Nonalcoholic Steatohepatitis (NASH) has become a major contributor to cirrhosis and liver cancer. Therefore, the Global Burden of Disease (GBD) 2017 was used to comprehensively analyze the global, regional, and national burden of cirrhosis and liver cancer due to NASH between 1990 and 2017. Data for cirrhosis and liver cancer due to NASH were extracted from the GBD study 2017. Socio-demographic Index (SDI) in 2017 was cited as indicators of socioeconomic status. ARIMA model was established to forecast the future health burden. Kruskal-Wallis test and Pearson linear correlation were adopted to evaluate the gender disparity and association with socioeconomic level. From 1990-2017, the global disability-adjusted life years (DALYs) numbers of liver cancer due to NASH increased from 0.71 million to 1.46 million. The age-standardized DALYs rates of liver cancer due to NASH were negatively associated with SDI levels (r=0.-409, p<0.001). Geographically, Australasia experienced the largest increase in the burden of liver cancer due to NASH, with the age-standardized DALYs rate increasing by 143.54%. The global prevalence number of liver cancer due to NASH peaked at 60-64 years in males and at 65-69 years in females. Globally, the burden was heavier in males compared with females. Male-female-ratio of age-standardized DALYs rates in liver cancer due to NASH were positively related to SDI (r=0.303, P=0.011). The global burden of NASH-associated liver cancer has increased significantly since 1990, with age, gender and geographic disparity. Public awareness of liver diseases due to NASH should be emphasized.
最近,非酒精性脂肪性肝炎(NASH)已成为肝硬化和肝癌的主要成因。因此,利用《2017年全球疾病负担(GBD)》全面分析了1990年至2017年间由NASH导致的肝硬化和肝癌的全球、区域和国家负担。从《2017年全球疾病负担研究》中提取了由NASH导致的肝硬化和肝癌的数据。引用2017年的社会人口指数(SDI)作为社会经济地位的指标。建立自回归积分滑动平均(ARIMA)模型来预测未来的健康负担。采用Kruskal-Wallis检验和Pearson线性相关性分析来评估性别差异以及与社会经济水平的关联。1990年至2017年,全球因NASH导致的肝癌伤残调整生命年(DALY)数从71万增加到146万。因NASH导致的肝癌年龄标准化DALY率与SDI水平呈负相关(r = -0.409,p < 0.001)。在地理分布上,大洋洲因NASH导致的肝癌负担增加幅度最大,年龄标准化DALY率增长了143.54%。全球因NASH导致的肝癌患病率在男性60 - 64岁、女性65 - 69岁时达到峰值。在全球范围内,男性的负担比女性更重。因NASH导致的肝癌年龄标准化DALY率的男女比例与SDI呈正相关(r = 0.303,P = 0.011)。自1990年以来,与NASH相关的肝癌全球负担显著增加,存在年龄、性别和地理差异。应强调公众对NASH所致肝脏疾病的认识。